Although monoallelic DUOX2 and DUOXA2 variants may occur in the general population, borderline transient CH may evade diagnosis on neonatal CH screening, such that apparently healthy mutation carriers satisfy criteria for inclusion in population genetic databases such as ExAC. This evidence concerns the gene DUOXA2 and cyclic hematopoiesis.